SCHEMBL4767719

SCHEMBL4767719

CCn1c(/C=C/c2cnn(Cc3ccccc3C(F)(F)F)c2)c([N+](=O)[O-])c(=O)n(CC)c1=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2B P29275 6/20 0.45
ADORA1 P30542 6/20 0.45
ADORA2A P29274 5/20 0.45
ALDH1A1 P00352 2/20 0.37
MAPK1 P28482 1/20 0.37
TAS2R8 Q9NYW2 1/20 0.36
SCD5 Q86SK9 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
MAPT P10636 2/20 0.34
POLB P06746 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
NPBWR1 P48145 1/20 0.34
ADORA3 P0DMS8 2/20 0.34
MITF O75030 2/20 0.33
NPC1 O15118 1/20 0.33
LMNA P02545 1/20 0.33
AGTR1 P30556 1/20 0.33
HTT P42858 1/20 0.33
RAB9A P51151 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4767733 1.00 ADORA2B (0.45) ADORA2BADORA1ADORA2AALDH1A1MAPK1
SCHEMBL4769690 0.95 ADORA2B (0.52) ADORA2BADORA1ADORA2AADORA3
SCHEMBL4769673 0.95 ADORA2B (0.52) ADORA2BADORA1ADORA2AADORA3
SCHEMBL4766145 0.91 ADORA2B (0.41) ADORA2BADORA1ADORA2AALDH1A1MAPK1
SCHEMBL4770754 0.90 ADORA2B (0.48) ADORA2BADORA1ADORA2AALDH1A1MAPK1
SCHEMBL4770747 0.90 ADORA2B (0.48) ADORA2BADORA1ADORA2AALDH1A1MAPK1
SCHEMBL4771046 0.90 ADORA2A (0.42) ADORA2BADORA1ADORA2AALDH1A1MAPK1
SCHEMBL4771033 0.90 ADORA2A (0.42) ADORA2BADORA1ADORA2AALDH1A1MAPK1
SCHEMBL4763491 0.89 ADORA2B (0.42) ADORA2BADORA1ADORA2AALDH1A1MAPT
SCHEMBL4763488 0.89 ADORA2B (0.42) ADORA2BADORA1ADORA2AALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678181-B1 A2B ADENOSINE RECEPTOR ANTAGONISTS CV THERAPEUTICS INC (US) 2008-12-31 EP disclosed